Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDH1 | O75874 | 17/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.34 |
| ▸ | KDM4B | O94953 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6276567 | 0.73 | IDH1 (0.41) | IDH1NR1I2KDM4BCHRM1TBXA2R | |
| SCHEMBL21762069 | 0.68 | IDH1 (0.42) | IDH1NR1I2KDM4BCHRM1TBXA2R | |
| SCHEMBL5409295 | 0.67 | SHMT2 (0.35) | SMN1; SMN2 | |
| SCHEMBL29020334 | 0.67 | CA1 (0.39) | KDM4EMAPK1SMN1; SMN2 | |
| SCHEMBL7087619 | 0.63 | IDH1 (0.46) | IDH1NR1I2KDM4BCHRM1TBXA2R | |
| SCHEMBL7089306 | 0.63 | IDH1 (0.65) | IDH1 | |
| Piroctone SCHEMBL28331516 | 0.63 | IDH1 (0.47) | IDH1 | |
| Piroctone SCHEMBL3588 | 0.63 | IDH1 (0.50) | IDH1 | |
| SCHEMBL6941621 | 0.63 | IDH1 (0.54) | IDH1 | |
| Piroctone SCHEMBL7568492 | 0.63 | IDH1 (0.50) | IDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118202009-A | Ink applicator | 墨水盒墨水公司 | 2024-06-14 | — | — | CN | claimed |
| CN-117462451-B | Antifungal agent-containing composition and preparation and application thereof | 拉芳家化股份有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-117462451-A | Antifungal agent-containing composition and preparation and application thereof | 拉芳家化股份有限公司 | 2024-01-30 | — | — | CN | claimed |
| US-20230218641-A1 | ANTI-ACNE COMPOSITIONS | L'OREAL (FR) | 2023-07-13 | — | — | US | claimed |
| CN-116267961-A | Mildew-proof method for natural rubber | 中国化工集团曙光橡胶工业研究设计院有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-116322621-A | Semi-permanent tattoo | 墨水盒墨水公司 | 2023-06-23 | — | — | CN | claimed |
| CN-115996980-A | Semi-permanent tattoo | 墨水盒墨水公司 | 2023-04-21 | — | — | CN | claimed |
| CN-115916147-A | Anti-acne composition | 欧莱雅 | 2023-04-04 | — | — | CN | claimed |
| EP-4153127-A1 | ANTI-ACNE COMPOSITIONS | L'OREAL (FR) | 2023-03-29 | — | — | EP | claimed |
| CN-115784981-A | Preparation process of piroctone olamine salt | 宿迁旭升化工有限公司 | 2023-03-14 | — | — | CN | claimed |
| CN-108430443-B | Cosmetic composition comprising anionic surfactant, at least 3.5% by weight of fatty acid and antidandruff agent | 欧莱雅 | 2023-01-03 | — | — | CN | claimed |
| WO-2021234014-A1 | ANTI-ACNE COMPOSITIONS | L'OREAL (FR) | 2021-11-25 | — | — | WO | claimed |
| US-20080119527-A1 | Composition for combating the localized hyperpigmentation of dark skin | L'OREAL (FR) | 2008-05-22 | — | — | US | claimed |
| EP-1900353-A1 | Composition to combat localised hyperpigmentation in dark skin types | L'OREAL (FR) | 2008-03-19 | — | — | EP | claimed |
| EP-0865278-A1 | USE OF 1-HYDROXY-2-PYRIDONES FOR TREATING MUCOSA DISEASES WHICH ARE DIFFICULT TO TREAT | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-09-23 | — | — | EP | claimed |
| WO-1997020560-A1 | USE OF 1-HYDROXY-2-PYRIDONES FOR TREATING MUCOSA DISEASES WHICH ARE DIFFICULT TO TREAT | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-06-12 | — | — | WO | claimed |
| EP-4739279-A1 | RED ALGAE BIOMASS EXTRACT, AND COSMETIC USE THEREOF FOR ELIMINATING SKIN IMPERFECTIONS | Fermentalg (FR) | 2026-05-13 | — | — | EP | disclosed |
| WO-2025012135-A1 | RED ALGAE BIOMASS EXTRACT, AND COSMETIC USE THEREOF FOR ELIMINATING SKIN IMPERFECTIONS | FERMENTALG (FR) | 2025-01-16 | — | — | WO | disclosed |
| EP-1064916-A1 | Cosmetic compositions containing an amphoteric polymer and an anti-dandruff agent and their uses | L'OREAL (FR) | 2001-01-03 | — | — | EP | disclosed |
| US-6162834-A | Foaming oil-in-water emulsion based on nonionic surfactants, a fatty phase and a crosslinked cationic or anionic polymer, and its use in topical applications | L'OREAL (FR) | 2000-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230218641-A1 | ANTI-ACNE COMPOSITIONS | CUTA, EBP, ACMSD | IDH1 4129/4885NR1I2 3471/4885KDM4B 3866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.